Cargando…
Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2
Background: Oxidized LDL(Ox-LDL) mediated endothelial dysfunction is involved in the pathogenesis of various cardiovascular diseases, including atherosclerosis. Azilsartan is a potent agent for the treatment of hypertension as the antagonist of the angiotensin II receptor. This study will investigat...
Autores principales: | Li, Wenfeng, Wang, Chenggao, Zhang, Dandan, Zeng, Kanghua, Xiao, Shihui, Chen, Feng, Luo, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148451/ https://www.ncbi.nlm.nih.gov/pubmed/33946046 http://dx.doi.org/10.18632/aging.202973 |
Ejemplares similares
-
Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6
por: Wang, Hao, et al.
Publicado: (2020) -
GPR120 Agonist GW9508 Ameliorated Cellular Senescence
Induced by ox-LDL
por: Liu, Ruijie, et al.
Publicado: (2020) -
IRF2BP2 prevents ox-LDL-induced inflammation and EMT in endothelial cells via regulation of KLF2
por: Jiang, Yongri, et al.
Publicado: (2021) -
Ox-LDL Induces Dysfunction of Endothelial Progenitor Cells via Activation of NF-κB
por: Ji, Kang-ting, et al.
Publicado: (2015) -
Humanin Ameliorates Free Fatty Acid-Induced Endothelial Inflammation
by Suppressing the NLRP3 Inflammasome
por: Li, Wenfeng, et al.
Publicado: (2020)